Haemophilus Influenzae (Hib) Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants
Condition: Prevention of Meningococcal DiseaseInterventions: Biological: MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation); Biological: MenACWY Ad+ (MenACWY-CRM, adjuvanted formulation); Biological: MenACWY PS (MenACWY-CRM, polysaccharide vaccine); Biological: HBV (Hepatitis B vaccine); Biological: Prevnar (pneumococcal polysaccharide serotypes 4, 9V, 14, 18C, 19F, 23F & 6B conjugated to the CRM197); Biological: MMR (Measles, Mumps and Rubella vaccine); Biological: DTaPHibIPV (Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine); Biological: Menj...
Source: ClinicalTrials.gov - December 2, 2005 Category: Research Source Type: clinical trials
